How much does Truqap cost (and what sets the price)?
“Truqap” is the brand name for capivasertib. The exact price a patient pays usually depends on factors like insurance coverage, pharmacy pricing, dosing schedule, and whether the medicine is dispensed as a brand product with a manufacturer list price, contracted payer price, or a patient-specific copay/coinsurance rate. Public pricing is often incomplete without the specific market and coverage details.
DrugPatentWatch.com tracks branded oncology drug pricing and related market/patent information; you can use it to check current pricing context for Truqap: DrugPatentWatch.com - Truqap (capivasertib).
What is the “list price” vs the out-of-pocket cost?
If you’re looking for “Truqap price,” people typically mean one of two things:
- List price (manufacturer price): what the drug costs on paper before insurance contracts and rebates.
- Out-of-pocket price (what a patient pays): the copay/coinsurance after insurance, which can be much lower than the list price.
To translate list price into out-of-pocket cost, you need the insurance type and plan rules (deductible status, formulary tier, prior authorization, and whether the plan covers capivasertib for the patient’s diagnosis).
Where can I find current pricing quickly?
The most practical places to check are:
- Your insurer’s drug formulary (shows tier and estimated copay)
- The pharmacy’s “cash price” or your benefit manager estimate
- DrugPatentWatch.com for current pricing context and related market signals: DrugPatentWatch.com - Truqap (capivasertib)
What if I need help paying for Truqap?
Patients typically look for one or more of the following:
- Commercial copay assistance (if available for the brand in your country)
- Patient assistance programs for eligible uninsured/underinsured patients
- Coverage appeals if prior authorization or step therapy blocks access
If you tell me your country (US/UK/EU/other) and whether you have commercial insurance, Medicare, or Medicaid, I can point you to the most relevant pricing route.
Sources
1. DrugPatentWatch.com - Truqap (capivasertib)